Colorectal Cancer
Conditions
Interventions
Sponsors
Huzhou Center Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with colorectal cancer through pathological diagnosis; 2. Possessing complete clinical pathological data (including TNM staging, histological classification, microsatellite status, etc.); 3. High-quality H&E stained pathological sections can be used for digital scanning; 4. The patient or their family member signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with benign diseases such as colorectal polyps and hemorrhoids; 2. Patients with hematological system diseases; 3. Patients with metastatic tumors in other parts of the body or those suffering from multiple other tumors at the same time; 4. Patients with mental illness or cognitive and communication dysfunction. 5. Influence data collectors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-Free Survival;Overall Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity;Precision;Recall;F1 Score;Dice Coefficient;Mean Average Precision;Accuracy of Immune Therapy Response Prediction;Area Under the Curve;Risk Stratification Ability;Correlation with Clinical Prognosis; | — |
Countries
China
Contacts
Public ContactLiu Jin
Huzhou Center Hospital
Outcome results
None listed